Psychopharmacologic treatment in juvenile offenders

Child and Adolescent Psychiatric Clinics of North America

Volumn 15, Issue 2, 2006, Pages 477-499

  Soller, Marie V ^a   Karnik, Niranjan S ^a,b,c   Steiner, Hans ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBAMAZEPINE; CHLORPROMAZINE; CITALOPRAM; CLONIDINE; DIPHENHYDRAMINE; DROPERIDOL; FLUOXETINE; HALOPERIDOL; HYPNOTIC SEDATIVE AGENT; LITHIUM; LORAZEPAM; MOLINDONE; MOOD STABILIZER; NADOLOL; OLANZAPINE; PAROXETINE; PIMOZIDE; PINDOLOL; PROPRANOLOL DERIVATIVE; RISPERIDONE; SERTRALINE; THIORIDAZINE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

ACUTE DISEASE; AGE DISTRIBUTION; AGGRESSION; AKATHISIA; APPETITE DISORDER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONDUCT DISORDER; CONSTIPATION; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG FORMULATION; DRUG MECHANISM; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FAMILY THERAPY; FATIGUE; GASTROINTESTINAL DISEASE; HEADACHE; HEMATOLOGIC DISEASE; HUMAN; HYPOTHYROIDISM; INSOMNIA; JUVENILE; LIVER DYSFUNCTION; LIVER TOXICITY; MENTAL DISEASE; NAUSEA; NEPHROTOXICITY; NERVOUSNESS; NEUTROPHILIA; PARADOXICAL DRUG REACTION; PARKINSONISM; PEDIATRICS; POLYURIA; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHIATRIC TREATMENT; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; RECIDIVISM; REVIEW; RISK FACTOR; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; TREATMENT PLANNING; TREMOR; URINARY DYSFUNCTION; URINARY FREQUENCY; VIOLENCE; VOMITING; WEIGHT GAIN;

ADOLESCENT; HUMANS; JUVENILE DELINQUENCY; MENTAL DISORDERS; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS;

EID: 33644760241     PISSN: 10564993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chc.2005.12.003     Document Type: Review

References (105)

1. L.A. Teplin, K.M. Abram, and G.M. McClelland Psychiatric disorders in youth in juvenile detention Arch Gen Psychiatry 59 12 2002 1133 1143
2. R. Vermeiren Psychopathology and delinquency in adolescents: a descriptive and developmental perspective Clin Psychol Rev 23 2 2003 277 318
3. G.A. Wasserman, L.S. McReynolds, and P. Fisher Psychiatric disorders in incarcerated youths J Am Acad Child Adolesc Psychiatry 42 9 2003 1011
4. E. Pappadopulos, J.C. Macintyre II, and M.L. Crismon Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II J Am Acad Child Adolesc Psychiatry 42 2 2003 145 161
5. S.B. Schur, L. Sikich, and R.L. Findling Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review J Am Acad Child Adolesc Psychiatry 42 2 2003 132 144
6. American Psychiatric Association Task Force on DSM-IV Diagnostic and statistical manual of mental disorders: DSM-IV-TR 2000 American Psychiatric Association Washington (DC)
7. World Health Organization The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines 1992 World Health Organization Geneva (Switzerland)
8. D.F. Connor Aggression and antisocial behavior in children and adolescents: research and treatment 2002 Guilford Press New York
9. J. Blair, B. Taggart, and A. Martin Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology J Neural Transm 111 7 2004 791 815
10. T. Grisso, R. Barnum, and K.E. Fletcher Massachusetts Youth Screening Instrument for mental health needs of juvenile justice youths J Am Acad Child Adolesc Psychiatry 40 5 2001 541 548
11. H. Steiner The scientific basis of mental health interventions in children and adolescents: an overview H. Steiner Handbook of mental health interventions in children and adolescents: an integrated developmental approach 2004 Jossey-Bass Publishers San Francisco (CA) 11 34
12. A.O. Battle, M.V. Battle, and E.A. Tolley Potential for suicide and aggression in delinquents at juvenile court in a southern city Suicide Life Threat Behav 23 3 1993 230 244
13. L. Farand, F. Chagnon, and J. Renaud Completed suicides among Quebec adolescents involved with juvenile justice and child welfare services Suicide Life Threat Behav 34 1 2004 24 35
14. T. Kempton, and R. Forehand Suicide attempts among juvenile delinquents; the contribution of mental health factors Behav Res Ther 30 5 1992 537 541
15. V.V. Ruchkin, M. Schwab-Stone, and R.A. Koposov Suicidal ideations and attempts in juvenile delinquents J Child Psychol Psychiatry 44 7 2003 1058 1066
16. C.R. Thomas, and J.V. Penn Juvenile justice mental health services Child Adolesc Psychiatr Clin N Am 11 4 2002 731 748
17. K.A. Busch, J. Fawcett, and D.G. Jacobs Clinical correlates of inpatient suicide J Clin Psychiatry 64 1 2003 14 19
18. J. Fawcett Treating impulsivity and anxiety in the suicidal patient Ann N Y Acad Sci 932 2001 94 102 [discussion 102-5]
19. Blair R.J., Coccaro E.F., Connor D.F., and members of the Workgroup on Juvenile Impulsivity and Aggression. The neuroscience of maladaptive aggression. J Am Acad Child Adolesc Psychiatry, in press
20. H. Steiner, K. Saxena, and K. Chang Psychopharmacologic strategies for the treatment of aggression in juveniles CNS Spectr 8 4 2003 298 308
21. H. Steiner, L. Delizonna, and K. Saxena Does the two-factor model of aggression hold incarcerated delinquents? Proceedings of the annual meeting of the American Psychiatric Association 2005 American Psychiatric Association Atlanta (GA) Available at: http://www.psych.org
22. M. Rana, L. Khanzode, and N. Karnik Divalproex sodium in the treatment of pediatric psychiatric disorders Expert Rev Neurother 5 2 2005 165 176
23. K. Saxena, L. Delizonna, and A. Durkin Divalproex sodium in outpatients with disruptive behavior disorders Proceedings of the annual meeting of the American Psychiatric Association 2005 American Psychiatric Association Atlanta (GA) Available at: http://www.psych.org
24. H. Steiner, M.L. Petersen, and K. Saxena Divalproex sodium for the treatment of conduct disorder: a randomized controlled clinical trial J Clin Psychiatry 64 10 2003 1183 1191
25. C.J. McDougle, K.A. Stigler, and D.J. Posey Treatment of aggression in children and adolescents with autism and conduct disorder J Clin Psychiatry 64 Suppl 4 2003 16 25
26. B. Vitiello, D. Behar, and J. Hunt Subtyping aggression in children and adolescents J Neuropsychiatry Clin Neurosci 2 2 1990 189 192
27. B. Vitiello, and D.M. Stoff Subtypes of aggression and their relevance to child psychiatry J Am Acad Child Adolesc Psychiatry 36 3 1997 307 315
28. M. Campbell, P.B. Adams, and A.M. Small Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study J Am Acad Child Adolesc Psychiatry 34 4 1995 445 453
29. M. Campbell, A.M. Small, and W.H. Green Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder Arch Gen Psychiatry 41 7 1984 650 656
30. R.P. Malone, J. Luebbert, and M. Pena-Ariet The Overt Aggression Scale in a study of lithium in aggressive conduct disorder Psychopharmacol Bull 30 2 1994 215 218
31. American Academy of Pediatrics Health care for children and adolescents in the juvenile correctional care system Pediatrics 107 4 2001 799 803
32. K.M. Abram, L.A. Teplin, and G.M. McClelland Comorbid psychiatric disorders in youth in juvenile detention Arch Gen Psychiatry 60 11 2003 1097 1108
33. R.A. Feinstein, A. Lampkin, and C.D. Lorish Medical status of adolescents at time of admission to a juvenile detention center J Adolesc Health 22 3 1998 190 196
34. A. Martin Pediatric psychopharmacology: principles and practice 2003 Oxford University Press Oxford (UK)
35. P.D. Riggs, S.K. Mikulich, and L.M. Coffman Fluoxetine in drug-dependent delinquents with major depression: an open trial J Child Adolesc Psychopharmacol 7 2 1997 87 95
36. K.D. Wagner, R. Berard, and M.B. Stein A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder Arch Gen Psychiatry 61 11 2004 1153 1162
37. D.A. Geller, K.D. Wagner, and G. Emslie Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial J Am Acad Child Adolesc Psychiatry 43 11 2004 1387 1396
38. M.B. Keller, N.D. Ryan, and M. Strober Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial J Am Acad Child Adolesc Psychiatry 40 7 2001 762 772
39. K.D. Wagner, A.S. Robb, and R.L. Findling A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents Am J Psychiatry 161 6 2004 1079 1083
40. K.D. Wagner Pharmacotherapy for major depression in children and adolescents Prog Neuropsychopharmacol Biol Psychiatry 29 5 2005 819 826
41. G.J. Emslie, A.J. Rush, and W.A. Weinberg A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression Arch Gen Psychiatry 54 11 1997 1031 1037
42. J.S. March, J. Biederman, and R. Wolkow Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial JAMA 280 20 1998 1752 1756
43. US Food and Drug Administration FDA public health advisory: suicidality in children and adolescents being treated with antidepressant medications 2004 US Food and Drug Administration Washington (DC)
44. R.D. Gibbons, K. Hur, and D.K. Bhaumik The relationship between antidepressant medication use and rate of suicide Arch Gen Psychiatry 62 2 2005 165 172
45. C.L. Donnelly Pharmacologic treatment approaches for children and adolescents with posttraumatic stress disorder Child Adolesc Psychiatr Clin N Am 12 2 2003 251 269
46. F.W. Putnam, and J.E. Hulsmann Pharmacotherapy for survivors of childhood trauma Semin Clin Neuropsychiatry 7 2 2002 129 136
47. B. Plattner, M.A. Silvermann, and A.D. Redlich Pathways to dissociation: intrafamilial versus extrafamilial trauma in juvenile delinquents J Nerv Ment Dis 191 12 2003 781 788
48. G.A. Keepers, V.J. Clappison, and D.E. Casey Initial anticholinergic prophylaxis for neuroleptic-induced extrapyramidal syndromes Arch Gen Psychiatry 40 10 1983 1113 1117
49. A.F. Schatzberg C.B. Nemeroff Textbook of psychopharmacology 2004 American Psychiatric Publishing Arlington (VA)
50. H.Y. Meltzer, J. Rabinowitz, and M.A. Lee Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance Am J Psychiatry 154 4 1997 475 482
51. J. Cheng-Shannon, J.J. McGough, and C. Pataki Second-generation antipsychotic medications in children and adolescents J Child Adolesc Psychopharmacol 14 3 2004 372 394
52. G.A. Bernstein, and K. Shaw Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders J Am Acad Child Adolesc Psychiatry 36 10 Suppl 1997 69S 84S
53. R.H. Lenox, and C.G. Hahn Overview of the mechanism of action of lithium in the brain: fifty-year update J Clin Psychiatry 61 Suppl 9 2000 5 15
54. D.F. Connor, S.J. Glatt, and I.D. Lopez Psychopharmacology and aggression. I: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD J Am Acad Child Adolesc Psychiatry 41 3 2002 253 261
55. S.E. McCabe, J.R. Knight, and C.J. Teter Non-medical use of prescription stimulants among US college students: prevalence and correlates from a national survey Addiction 100 1 2005 96 106
56. S.E. McCabe, C.J. Teter, and C.J. Boyd Prevalence and correlates of illicit methylphenidate use among 8th, 10th, and 12th grade students in the United States, 2001 J Adolesc Health 35 6 2004 501 504
57. C.J. Teter, S.E. McCabe, and C.J. Boyd Illicit methylphenidate use in an undergraduate student sample: prevalence and risk factors Pharmacotherapy 23 5 2003 609 617
58. S. Kaplan, J. Heiligenstein, and S. West Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder J Atten Disord 8 2 2004 45 52
59. J.H. Newcorn, T.J. Spencer, and J. Biederman Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder J Am Acad Child Adolesc Psychiatry 44 3 2005 240 248
60. D. Michelson, D. Faries, and J. Wernicke Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study Pediatrics 108 5 2001 E83
61. H. Steiner Handbook of mental health interventions in children and adolescents: an integrated developmental approach 2004 Jossey-Bass Publishers San Francisco (CA)
62. C.B. Nemeroff, C.M. Heim, and M.E. Thase Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma Proc Natl Acad Sci U S A 100 24 2003 14293 14296
63. V.G. Carrion, and H. Steiner Trauma and dissociation in delinquent adolescents J Am Acad Child Adolesc Psychiatry 39 3 2000 353 359
64. E. Cauffman, S.S. Feldman, and J. Waterman Posttraumatic stress disorder among female juvenile offenders J Am Acad Child Adolesc Psychiatry 37 11 1998 1209 1216
65. L.E. Arnold, S. Chuang, and M. Davies Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures J Abnorm Child Psychol 32 1 2004 39 51
66. R.A. Williams, H.M. Hollis, and K. Benoit Attitudes toward psychiatric medications among incarcerated female adolescents J Am Acad Child Adolesc Psychiatry 37 12 1998 1301 1307
67. W. Arroyo Children, adolescents, and families Ethics primer of the American Psychiatric Association 2001 American Psychiatric Publishing, Inc. Washington (DC) 11 22
68. M.K. Nickel, C. Nickel, and P. Leiberich Aggressive female youth benefit from outpatient family therapy: a randomized, prospective, controlled trial Pediatr Int 47 2 2005 167 171
69. W. Arroyo, W. Buzogany, and G. Hanson Recommendations for juvenile justice reform 2001 American Academy of Child and Adolescent Psychiatry Washington (DC)
70. M.G. Aman, R.E. Marks, and S.H. Turbott Clinical effects of methylphenidate and thioridazine in intellectually subaverage children J Am Acad Child Adolesc Psychiatry 30 2 1991 246 256
71. L.L. Greenhill, M. Solomon, and R. Pleak Molindone hydrochloride treatment of hospitalized children with conduct disorder J Clin Psychiatry 46 8 Pt 2 1985 20 25
72. J.P. Broche [Use of pimozide (ORAP) in child psychiatry (author's transl)] Acta Psychiatr Belg 80 3 1980 341 346
73. P.T. Joshi, L. Hamel, and A.R. Joshi Use of droperidol in hospitalized children J Am Acad Child Adolesc Psychiatry 37 2 1998 228 230
74. O. Hameer, K. Collin, and M.H. Ensom Evaluation of droperidol in the acutely agitated child or adolescent Can J Psychiatry 46 9 2001 864 865
75. R.L. Findling, N.K. McNamara, and L.A. Branicky A double-blind pilot study of risperidone in the treatment of conduct disorder J Am Acad Child Adolesc Psychiatry 39 4 2000 509 516
76. R. Snyder, A. Turgay, and M. Aman Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs J Am Acad Child Adolesc Psychiatry 41 9 2002 1026 1036
77. R.L. Findling, M.G. Aman, and M. Eerdekens Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ Am J Psychiatry 161 4 2004 677 684
78. M. Aman, J. Buitelaar, and G.D. Smedt Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: pooled analysis of risperidone effects in children with subaverage IQ J Child Adolesc Psychopharmacol 15 2 2005 220 232
79. J. Croonenberghs, J.M. Fegert, and R.L. Findling Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients J Am Acad Child Adolesc Psychiatry 44 1 2005 64 72
80. H. Soderstrom, M. Rastam, and C. Gillberg A clinical case series of six extremely aggressive youths treated with olanzapine Eur Child Adolesc Psychiatry 11 3 2002 138 141
81. R.J. Stephens, C. Bassel, and P. Sandor Olanzapine in the treatment of aggression and tics in children with Tourette's syndrome-a pilot study J Child Adolesc Psychopharmacol 14 2 2004 255 266
82. V. Kafantaris, M. Campbell, and M.V. Padron-Gayol Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study Psychopharmacol Bull 28 2 1992 193 199
83. J.A. Mattes Comparative effectiveness of carbamazepine and propranolol for rage outbursts J Neuropsychiatry Clin Neurosci 2 2 1990 159 164
84. J.E. Cueva, J.E. Overall, and A.M. Small Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study J Am Acad Child Adolesc Psychiatry 35 4 1996 480 490
85. S.J. Donovan, J.W. Stewart, and E.V. Nunes Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design Am J Psychiatry 157 5 2000 818 820
86. R.P. Malone, M.A. Delaney, and J.F. Luebbert A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder Arch Gen Psychiatry 57 7 2000 649 654
87. A. Rifkin, B. Karajgi, and R. Dicker Lithium treatment of conduct disorders in adolescents Am J Psychiatry 154 4 1997 554 555
88. E.F. Coccaro, R.J. Kavoussi, and R.L. Hauger Serotonin function and antiaggressive response to fluoxetine: a pilot study Biol Psychiatry 42 7 1997 546 552
89. J.N. Constantino, M. Liberman, and M. Kincaid Effects of serotonin reuptake inhibitors on aggressive behavior in psychiatrically hospitalized adolescents: results of an open trial J Child Adolesc Psychopharmacol 7 1 1997 31 44
90. D.R. Cherek, S.D. Lane, and C.J. Pietras Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder Psychopharmacology (Berl) 159 3 2002 266 274
91. J.L. Armenteros, and J.E. Lewis Citalopram treatment for impulsive aggression in children and adolescents: an open pilot study J Am Acad Child Adolesc Psychiatry 41 5 2002 522 529
92. J.K. Zubieta, and N.E. Alessi Acute and chronic administration of trazodone in the treatment of disruptive behavior disorders in children J Clin Psychopharmacol 12 5 1992 346 351
93. R.G. Klein, H. Abikoff, and E. Klass Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder Arch Gen Psychiatry 54 12 1997 1073 1080
94. S.L. Kaplan, J. Busner, and S. Kupietz Effects of methylphenidate on adolescents with aggressive conduct disorder and ADDH: a preliminary report J Am Acad Child Adolesc Psychiatry 29 5 1990 719 723
95. P.L. Hazell, and J.E. Stuart A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children J Am Acad Child Adolesc Psychiatry 42 8 2003 886 894
96. J.P. Kemph, C.L. DeVane, and G.M. Levin Treatment of aggressive children with clonidine: results of an open pilot study J Am Acad Child Adolesc Psychiatry 32 3 1993 577 581
97. T.J. Schvehla, M.W. Mandoki, and G.S. Sumner Clonidine therapy for comorbid attention deficit hyperactivity disorder and conduct disorder: preliminary findings in a children's inpatient unit South Med J 87 7 1994 692 695
98. J.M. Silver, S.C. Yudofsky, and J.A. Slater Propranolol treatment of chronically hospitalized aggressive patients J Neuropsychiatry Clin Neurosci 11 3 1999 328 335
99. S. Kuperman, and M.A. Stewart Use of propranolol to decrease aggressive outbursts in younger patients Open study reveals potentially favorable outcome. Psychosomatics 28 6 1987 315 319
100. D.F. Connor, K.R. Ozbayrak, and S. Benjamin A pilot study of nadolol for overt aggression in developmentally delayed individuals J Am Acad Child Adolesc Psychiatry 36 6 1997 826 834
101. J.K. Buitelaar, R.J. van der Gaag, and H. Swaab-Barneveld Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects J Child Psychol Psychiatry 37 5 1996 587 595
102. C.R. Pfeffer, H. Jiang, and L.J. Domeshek Buspirone treatment of psychiatrically hospitalized prepubertal children with symptoms of anxiety and moderately severe aggression J Child Adolesc Psychopharmacol 7 3 1997 145 155
103. S.W. Stanislav, T. Fabre, and M.L. Crismon Buspirone's efficacy in organic-induced aggression J Clin Psychopharmacol 14 2 1994 126 130
104. B. Vitiello, J.L. Hill, and J. Elia P.r.n. medications in child psychiatric patients: a pilot placebo-controlled study J Clin Psychiatry 52 12 1991 499 501
105. B.H. King, D.M. Wright, and M. Snape Case series: amantadine open-label treatment of impulsive and aggressive behavior in hospitalized children with developmental disabilities J Am Acad Child Adolesc Psychiatry 40 6 2001 654 657